PMID: 2112251Jun 1, 1990Paper

Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations

Proceedings of the National Academy of Sciences of the United States of America
H KitayamaM Noda

Abstract

Kirsten-ras-revertant 1 (Krev-1) cDNA encodes a ras-related protein and exhibits an activity of inducing flat revertants at certain frequencies (2-5% of total transfectants) when introduced into a v-K-ras-transformed mouse NIH 3T3 cell line, DT. Toward understanding the mechanism of action of Krev-1 protein, we constructed a series of point mutants of Krev-1 cDNA and tested their biological activities in DT cells and HT1080 human fibrosarcoma cells harboring the activated N-ras gene. Substitutions of the amino acid residues in the putative guanine nucleotide-binding regions (Asp17 and Asn116), in the putative effector-binding domain (residue 38), at the putative acylation site (Cys181), and at the unique Thr61 all decreased the transformation suppressor activity. On the other hand, substitutions such as Gly12 to Val12 and Gln63 to Glu63 were found to significantly increase the transformation suppressor/tumor suppressor activity of Krev-1. These findings are consistent with the idea that Krev-1 protein is regulated like many other G proteins by the guanine triphosphate/guanine diphosphate-exchange mechanism probably in response to certain negative growth-regulatory signals.

References

Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I S SigalE M Scolnick
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M NodaY Ikawa
Jul 21, 1989·Science·L TongS H Kim
Jan 1, 1987·Annual Review of Biochemistry·M Barbacid
Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I S SigalE M Scolnick
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A Fujiyama, F Tamanoi
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·O FasanoM Wigler
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·M NodaR H Bassin

❮ Previous
Next ❯

Citations

Jan 1, 1990·Molecular Carcinogenesis·M Noda
Jan 1, 1992·Molecular Carcinogenesis·J CaamanoA J Klein-Szanto
Apr 13, 1995·Biochimica Et Biophysica Acta·O UrayamaY Ikawa
Dec 10, 1991·Biochimica Et Biophysica Acta·H Haubruck, F McCormick
Mar 1, 1994·Cellular Signalling·L Wiesmüller, F Wittinghofer
Jan 1, 1994·Trends in Cardiovascular Medicine·B T Kinsella, D J O'Mahony
Jan 1, 1996·Progress in Biophysics and Molecular Biology·C Herrmann, N Nassar
May 3, 2003·Pharmacology & Therapeutics·Leonidas C Platanias
Nov 24, 1999·Experimental Hematology·L C Platanias, E N Fish
Feb 13, 2001·British Journal of Haematology·I M GrumbachL C Platanias
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M NakafukuY Kaziro
Dec 1, 1992·Molecular Biology of the Cell·M S Nur-E-Kamal, H Maruta
Mar 10, 2001·Molecular and Cellular Biology·O M TsygankovaJ L Meinkoth
Feb 23, 2010·BMC Evolutionary Biology·Tomasz ZemojtelFried J T Zwartkruis
Jul 14, 2010·Future Oncology·Makoto NodaHitoshi Kitayama
Aug 3, 2002·Leukemia & Lymphoma·Amit Verma, Leonidas C Platanias
Dec 21, 2004·Journal of Biochemistry and Molecular Biology·Shahab Uddin, Leonidas C Platanias
Oct 8, 2004·Developmental Cell·Esther M LafuenteVassiliki A Boussiotis
May 1, 1990·Japanese Journal of Cancer Research : Gann·H KitayamaM Noda
Dec 31, 1997·The Journal of Biological Chemistry·S AhmadL C Platanias
Jan 25, 2003·Oncogene·Elena VigoritoMartin Turner
Mar 14, 2000·The Journal of Biological Chemistry·E M PalssonL A O'Neill
Apr 18, 1997·The Journal of Biological Chemistry·G J ClarkC J Der
Jan 5, 1999·The Journal of Biological Chemistry·E N FishL C Platanias
Jan 19, 1996·The Journal of Biological Chemistry·T OhtsukaY Takai
Nov 22, 1996·The Journal of Biological Chemistry·S N PetersonG C White

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.